Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
about
Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the diseaseCardiac cachexia: hic et nuncAdiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failureSerum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart FailureEffects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non-Small Cell Lung Cancer.Effect of macronutrients, age, and obesity on 6- and 24-h postprandial glucose metabolism in catsEffects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)Emerging biomarkers in heart failure and cardiac cachexiaBody mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction.Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure.Dysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels.N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failureHypoadiponectinemia in patients with paroxysmal atrial fibrillationAdipose tissue biology and cardiomyopathy: translational implications.Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model.Adiponectin, diabetes and ischemic heart failure: a challenging relationship.Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis.Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease.Circulating Adiponectin Levels Following Treatment Can Predict Late Clinical Outcomes in Chronic Heart Failure.Functional adiponectin resistance and exercise intolerance in heart failure.Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review.Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats.Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.Direct effects of adipokines on the heart: focus on adiponectin.Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?Cancer cachexia update in head and neck cancer: Definitions and diagnostic features.Relationship between adiponectin, obesity and insulin resistance.Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis.NT-Pro-B-Type Natriuretic Peptide Levels in Infants with Failure to Thrive due to Caloric Deprivation.Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men.A new role for the natriuretic peptides: metabolic regulators of the adipocytePrevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.Adipocytokines and risk of stroke in older people: a nested case-control study.
P2860
Q21284666-A1E6355B-96B8-4CA6-A9A8-0BD2092180C6Q26744140-A32FAF2E-0642-46C6-9255-8E360E47D5F4Q26745026-65CA48CE-60E6-480A-830B-25D56CFE8E13Q28548351-3E8D48D1-C5AB-447E-8F2E-9D5DCA150816Q33574769-4EB98CE4-5F3E-4AC8-A4EC-8B6290B6234BQ33816580-FC45FA9E-1936-45D7-9691-972CFB8525C2Q33917163-D12C8E60-267F-4707-9E43-56422FBF01A9Q34681621-8DDBD916-B4E3-4B60-B2FF-FF9DBD456EC9Q34697156-A9C273F4-D26E-4B1C-9215-4F7C9F8B3B52Q34836097-15E656FD-A31D-4909-BB1E-A5D33C105DADQ35003806-DF82A3CB-5557-47B2-AF8A-AAFBB63CAF47Q35581324-3F74E6C6-AC9C-4B06-B7CF-A00C7BA64176Q35683266-DC869881-0EC8-40CA-B7DD-AC6C0804988CQ36199888-344CBFD0-4017-42FB-A4C2-2C3264DFAF3DQ36298248-6F8570C8-6E5A-491D-9E36-65D5E6B14BD3Q36385440-B6EAF22E-55AE-471F-B01B-759D68DE770EQ36496035-0860EEE6-5996-4357-9B9C-821CA1288594Q36510256-EAAA2CD5-A443-404F-853D-57D9F4397337Q36571908-C81D3CE4-D49E-4EDD-BBC0-DE39F13394E5Q36732747-F86996F4-A44C-4F38-8794-9CBCA474D1FDQ37275149-8B7DBF17-8298-4F41-A761-EF2BA1F1E809Q37719007-914EC971-F363-4E5C-9DB5-9B7764099CAFQ37855653-8BE2B994-5116-46EA-A756-32F18D7253DBQ37890195-29E983D1-42EA-403E-BA7C-20F9C71E7C4EQ37960096-9AB8F4EB-65D3-4DB1-97C6-C1E1629593A0Q38017586-19B6BF83-A6B7-44C4-B020-B6F1A4D3505BQ38034678-4741B2A8-5F3E-4A7B-A3B8-3F25B367C236Q38035745-1CF27184-A859-4781-BD45-8DBD7C048F42Q38054603-0EFA4C57-316F-463D-A209-6A46C0DF51AFQ38077655-4EA14B41-5817-4D59-A0BE-BB8631D10BD8Q38177750-2C1D03F9-D4AA-4BC3-B518-12549C49B6ECQ38440408-B9FBE2AC-3B60-4409-9FAE-9CEB1A55BD3EQ38954621-16174333-90ED-4175-B29F-6E26172CF5C0Q39871447-3A9BA097-E181-4C47-8334-395BEB52BEA7Q40376725-AA3ACB81-1B5E-43F0-A934-3165F8672F39Q41690788-ACF570C2-4B09-4DB3-97AC-287C993EF85CQ42013167-7AA64799-FFDA-4DDA-A19F-AF3EA113F9E9Q42761019-47CDD7BA-2A63-469A-AFFA-F11CCBA873A0Q45150879-16C5F338-8A9D-447E-987F-4A6AD2E17F83Q46295029-945E164E-D50F-4E57-B2D2-5CF8E045DD8D
P2860
Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Increase in serum adiponectin ...... nd B-type natriuretic peptide.
@en
Increase in serum adiponectin ...... nd B-type natriuretic peptide.
@nl
type
label
Increase in serum adiponectin ...... nd B-type natriuretic peptide.
@en
Increase in serum adiponectin ...... nd B-type natriuretic peptide.
@nl
prefLabel
Increase in serum adiponectin ...... nd B-type natriuretic peptide.
@en
Increase in serum adiponectin ...... nd B-type natriuretic peptide.
@nl
P2093
P356
P1476
Increase in serum adiponectin ...... nd B-type natriuretic peptide.
@en
P2093
Bonaventure Awede
Francis G Dunn
John J V McMurray
Margaret B McEntegart
Mark C Petrie
Niall G MacFarlane
P304
P356
10.1093/EURHEARTJ/EHM033
P577
2007-04-02T00:00:00Z